View Item 

Show simple item record

Efficacy And Safety Of Tisagenlecleucel (Tisa‐Cel) In Adult Patients (Pts) With Relapsed/Refractory Follicular Lymphoma (R/R Fl): Primary Analysis Of The Phase 2 Elara Trial
dc.contributor.authorSchuster, S. J.
dc.contributor.authorDickinson, M.
dc.contributor.authorDreyling, M.
dc.contributor.authorMartinez‐lopez, J.
dc.contributor.authorKolstad, A.
dc.contributor.authorButler, J.
dc.contributor.authorGhosh, M.
dc.contributor.authorPopplewell, L.
dc.contributor.authorChavez, J. C.
dc.contributor.authorBachy, E.
dc.contributor.authorKato, K.
dc.contributor.authorHarigae, H.
dc.contributor.authorKersten, M. José
dc.contributor.authorAndreadis, C.
dc.contributor.authorRiedell, P. A.
dc.contributor.authorAbdelhady, A.
dc.contributor.authorZia, A.
dc.contributor.authorMorisse, M. C.
dc.contributor.authorFowler, N. H.
dc.contributor.authorThieblemont, C.
dc.date.accessioned2021-07-01T20:10:14Z
dc.date.available2022-07-01 16:10:14en
dc.date.available2021-07-01T20:10:14Z
dc.date.issued2021-06
dc.identifier.citationSchuster, S. J.; Dickinson, M.; Dreyling, M.; Martinez‐lopez, J. ; Kolstad, A.; Butler, J.; Ghosh, M.; Popplewell, L.; Chavez, J. C.; Bachy, E.; Kato, K.; Harigae, H.; Kersten, M. José ; Andreadis, C.; Riedell, P. A.; Abdelhady, A.; Zia, A.; Morisse, M. C.; Fowler, N. H.; Thieblemont, C. (2021). "Efficacy And Safety Of Tisagenlecleucel (Tisa‐Cel) In Adult Patients (Pts) With Relapsed/Refractory Follicular Lymphoma (R/R Fl): Primary Analysis Of The Phase 2 Elara Trial." Hematological Oncology 39: n/a-n/a.
dc.identifier.issn0278-0232
dc.identifier.issn1099-1069
dc.identifier.urihttps://hdl.handle.net/2027.42/168253
dc.publisherWiley Periodicals, Inc.
dc.subject.otherCellular therapies
dc.subject.otherIndolent non- Hodgkin lymphoma
dc.titleEfficacy And Safety Of Tisagenlecleucel (Tisa‐Cel) In Adult Patients (Pts) With Relapsed/Refractory Follicular Lymphoma (R/R Fl): Primary Analysis Of The Phase 2 Elara Trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelOphthalmology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168253/1/hon85_2879.pdf
dc.identifier.doi10.1002/hon.85_2879
dc.identifier.sourceHematological Oncology
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hon85_2879.pdf
Size:
150.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.